Related Experiment Video

Updated: Mar 27, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

843

Tumor Microenvironment-Responsive Nanomedicine: Monitoring and Modulating the Tumor Microenvironment for Precision

Jiejie He1, Weiwei Xue2, Yan Li1

  • 1Department of Gynecologic Oncology, Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, Qinghai, 810000, People's Republic of China.

International Journal of Nanomedicine
|March 26, 2026
PubMed

Insights

Tumor microenvironment (TME)-responsive nanomedicines offer a novel approach to overcome drug delivery challenges in cancer. These nanomedicines can monitor and remodel the TME, improving precision cancer therapy and patient outcomes.

Area of Science:

  • Nanomedicine
  • Cancer Biology
  • Drug Delivery

Background:

  • The tumor microenvironment (TME) presents significant barriers to cancer therapy due to abnormal vasculature, dense extracellular matrix, metabolic reprogramming, and immunosuppression.
  • These factors hinder drug penetration, promote therapeutic resistance, and limit immunotherapy effectiveness.

Purpose of the Study:

  • To review the pathological features of the TME and their impact on drug delivery across various biological barriers.
  • To discuss the design principles of TME-responsive nanoplatforms for monitoring and modulating the TME.
  • To highlight translational challenges and future opportunities for TME-responsive nanomedicines.

Main Methods:

  • Summarized key pathological features of the TME and their influence on drug delivery.
  • Discussed design principles of endogenous and exogenous stimuli-responsive nanoplatforms.
  • Reviewed TME monitoring techniques (liquid biopsy, spatial multi-omics, real-time imaging) and modulation strategies (metabolic reprogramming, immune activation, vascular normalization, ECM remodeling).

Main Results:

  • TME-responsive nanomedicines can be designed to monitor and actively remodel the tumor microenvironment.
  • These nanoplatforms enable TME monitoring through advanced techniques and facilitate therapeutic modulation.
  • Key pathological features of the TME significantly impact drug delivery across diverse biological barriers.

Conclusions:

  • TME-responsive nanomedicines represent a promising strategy for precision cancer therapy by overcoming drug delivery barriers.
  • Future directions include leveraging artificial intelligence and advanced modeling for optimizing nanomedicine efficacy.
  • Closed-loop theranostic strategies are crucial for translating TME-responsive nanomedicines into clinical benefits.
Keywords:
nanomedicineprecision cancer therapystimuli-responsive drug deliverytheranostic nanoparticlestumor microenvironment

More Related Videos

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.6K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

5.7K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

3.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K